Introduction
There are moments in clinical work where something important is clearly happening—but it doesn’t organize into something that can be easily accessed, articulated, or meaningfully changed.
Insight may be present.
The therapeutic relationship may be established. The work may be active.
And still, the response persists.
These moments don’t reflect a limitation of any single modality. They point to something more specific: that certain aspects of experience can remain difficult to access, organize, and work with in real time—particularly through verbal processing alone.
This blog begins from that shared clinical reality.
It explores how psychedelic-assisted psychotherapy—a structured therapeutic process that uses carefully supported altered states of consciousness to deepen clinical work—may offer another way of engaging these moments.
Importantly, this refers to therapy that includes preparation, a guided medicine session, and integration—not simply the use of substances in isolation.
Drawing from trauma research, mindfulness-based approaches, Internal Family Systems (IFS), and relational psychotherapy, the aim is not to redefine existing work but to consider where it sometimes reaches its edge—and what may become possible when those edges are approached differently.
For clinicians, this isn’t a “how-to,” nor an argument for a single approach. It’s a grounded exploration of an emerging area of practice, shaped by a familiar question:
What supports change when insight alone isn’t enough, and experience remains resistant to meaningful change despite ongoing work across modalities?
Where clinical work starts to feel limited
Clinical work often highlights moments where something important is happening, but remains difficult to access, organize, or meaningfully change in real time—particularly when insight alone doesn’t seem to move the process forward.
Not in a theoretical sense—but in the moment.
When something is clearly active, but doesn’t organize into language.
When understanding is present, but the reaction persists.
When the work is happening, but not in a way that follows a predictable or linear path.
Dr. Bessel van der Kolk has described one version of this in neurobiological terms. During traumatic activation, regions associated with language and narrative organization may become less active. Broca’s area, in particular, can go offline.
What remains is what he refers to as “speechless terror.” (van der Kolk, 2014)
In practice, this doesn’t always appear dramatically. More often, it shows up as something quieter:
- experience that doesn’t fully translate into words • reactions that persist despite insight
- material that feels active, but not fully accessible
This is not a failure of therapy. It reflects something about how experience is organized under certain conditions.
And it raises a question that tends to sit underneath clinical work:
What supports change when insight is present, but doesn’t fully alter what’s happening?
What we mean by psychedelic-assisted psychotherapy
Over several decades, one area of growing clinical interest has been psychedelic-assisted psychotherapy.
Before going further, it’s important to be clear about what that actually refers to.
Psychedelic-assisted psychotherapy is not:
- the administration of a substance in isolation
- a passive infusion model
- or a pharmacological intervention without therapeutic structure It’s a structured, relational process that includes:
- preparation
- a supported medicine session
- and integration over time
Within this model, the substance functions as: a catalyst—not the treatment itself
The therapeutic work remains central; the altered state may expand what can be accessed within it. And critically, the therapeutic relationship and integration often influence the extent to which meaningful change can occur.
What shifts in altered states
In psychedelic-assisted work, what often changes first isn’t the content of experience, but the structure through which it’s interpreted.
Dr. Philip Wolfson describes ketamine as interrupting the “obsessional mind”—patterns that have become repetitive and self-reinforcing.
At a neurobiological level, ketamine’s action as an NMDA receptor antagonist is associated with increased glutamate signaling and downstream changes in synaptic plasticity (Duman & Aghajanian, 2012; Krystal et al., 2019). Clinically, this has been linked to a temporary loosening of rigid cognitive and emotional patterns.
“Ketamine is not the treatment. The experience is the treatment.” (Wolfson, 2016)
The distinction matters.
The therapeutic potential appears to emerge not from the substance alone, but from how the altered state is experienced, supported, and integrated.
This becomes particularly relevant in moments where verbal processing alone hasn’t been sufficient to change entrenched patterns meaningfully.
Clinical trials have demonstrated reductions in trauma-related symptoms following ketamine administration in controlled settings (Feder et al., 2014), though outcomes appear closely tied to context and follow-up care.
When the system becomes more visible
As rigidity decreases, internal complexity often becomes more apparent.
Dr. Richard Schwartz’s Internal Family Systems (IFS) model offers one way of understanding this.
Rather than a single, unified system, experience may be organized into different parts:
- protective
- reactive
- or carrying unresolved material
“There are no bad parts.” (Schwartz, 2013)
In altered states, these dynamics may be encountered more directly.
Increased access does not eliminate the need for pacing or internal permission—particularly when material has been difficult to reach through conventional means.
How experience is related to
As internal experience becomes more available, the focus shifts: not just what emerges, but how it’s related to.
Dr. Ronald Siegel notes: “Suffering is not pain itself, but the resistance to pain.” (Siegel, 2010)
Patterns of over-identification or avoidance often intensify distress.
Mindfulness-based approaches support:
- observing without immediate reaction
- increasing tolerance for internal states
- allowing experience to unfold
In altered states, this becomes less conceptual and more practical.
The role of the clinician
As the process deepens, the role of the clinician becomes more visible.
Dr. Janis Phelps emphasizes that the therapist supports inner-directed healing, rather than directing it (Phelps, n.d.).
This requires:
- presence
- restraint
- and the ability to hold experience without shaping it prematurely
Because in these states, the clinician isn’t neutral—they’re part of the environment.
Why relationship still matters most
Across models, the role of relationship remains central.
Dr. Gita Vaid describes therapy as occurring within a relational field: “The relational field is the primary medium through which transformation becomes possible.” (Vaid, n.d.)
Change appears to stabilize not through insight alone, but through:
- safety
- continuity
- and repeated relational experience
What determines whether anything actually changes
Ultimately, the question isn’t what happens in the session—it’s what changes when the client returns to ordinary states of consciousness.
Integration involves:
- translating experience into daily life
- increasing flexibility
- reducing automatic reactivity
Across approaches, a consistent pattern emerges: change may involve expanding what can be experienced without triggering avoidance or loss of regulation.
Often, this shows up in small ways:
- a pause
- a shift in response
- the ability to stay with something that previously overwhelmed
Where this leaves us
Psychedelic-assisted psychotherapy doesn’t replace existing approaches.
It may, in certain contexts, extend them—particularly in moments where insight and verbal processing alone haven’t been sufficient to meaningfully change what’s occurring.
The altered state may open something.
The therapeutic relationship helps hold it.
And integration determines whether it stays.
For those interested in the growing research base, clinical studies in ketamine, MDMA, and other forms of psychedelic-assisted psychotherapy continue to expand, particularly in the treatment of trauma and treatment-resistant depression.
At its core, this work doesn’t move away from what clinicians already value. It remains grounded in relationship, attunement, and careful pacing.
What it may offer is another way of engaging moments that are otherwise difficult to reach— when something is present, but not yet accessible, organized, or able to meaningfully change through insight alone.
References
van der Kolk, B. A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking.
Duman, R. S., & Aghajanian, G. K. (2012). Synaptic dysfunction in depression: Potential therapeutic targets. Science, 338(6103), 68–72.
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood,
K., Aan Het Rot, M., Lapidus, K. A. B., Wan, L.-B., Iosifescu, D., Charney, D. S., & Mathew, S. J. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681–688
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (2011). Acceptance and commitment therapy: The process and practice of mindful change (2nd ed.). Guilford Press.
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. (2019). Ketamine: A paradigm shift for depression research and treatment. Neuron, 101(5), 774–778.
Phelps, J. (n.d.). Psychedelic-assisted psychotherapy training model. Multidisciplinary Association for Psychedelic Studies (MAPS).
Schwartz, R. C. (2013). Internal family systems therapy (2nd ed.). Guilford Press.
Siegel, R. D. (2010). The mindfulness solution: Everyday practices for everyday problems. Guilford Press.
Wolfson, P. E. (Ed.). (2016). The ketamine papers: Science, therapy, and transformation. Multidisciplinary Association for Psychedelic Studies.
Vaid, G. (n.d.). Transformative psychotherapy and relational field model. Unpublished clinical framework.
